SEQENS Group
- Home
- Companies
- SEQENS Group
- Products
- Anastrozole
Anastrozole
FromSEQENS Group
Anastrozole is a competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of postmenopausal women with estrogen-responsive breast cancer.
Most popular related searches
- Product Name: Anastrozole
- CAS Number: 120511-73-1
- Therapeutic Class: Antineoplastic, Aromatase Inhibitor
- Dosage Form: Oral tablet
- Availability: Commercial
- Regulatory Status: EDMF